Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain

Hamilton, A. and Patterson, S. and Porter, David and Gault, Victor A. and Hölscher, Christian (2011) Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain. Journal of Neuroscience Research, 89 (4). pp. 481-489. ISSN 0360-4012

Full text not available from this repository.

Abstract

One of the symptoms of diabetes is the progressive development of neuropathies. One mechanism to replace neurons in the CNS is through the activation of stem cells and neuronal progenitor cells. We have tested the effects of the novel GLP-1 mimetics exenatide (exendin-4; Byetta) and liraglutide (NN2211; Victoza), which are already on the market as treatments for type 2 diabetes, on the proliferation rate of progenitor cells and differentiation into neurons in the dentate gyrus of brains of mouse models of diabetes. GLP-1 analogues were injected subcutaneously for 4, 6, or 10 weeks once daily in three mouse models of diabetes: ob/ob mice, db/db mice, or high-fat-diet-fed mice. Twenty-four hours before perfusion, animals were injected with 5'-bromo-2'-deoxyuridine (BrdU) to mark dividing progenitor cells. By using immunohistochemistry and stereological methods, the number of progenitor cells or doublecortin-positive young neurons in the dentate gyrus was estimated. We found that, in all three mouse models, progenitor cell division was enhanced compared with nondiabetic controls after chronic i.p. injection of either liraglutide or exendin-4 by 100-150% (P

Item Type:
Journal Article
Journal or Publication Title:
Journal of Neuroscience Research
Additional Information:
Copyright © 2011 Wiley-Liss, Inc.
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/2800/2804
Subjects:
ID Code:
69061
Deposited By:
Deposited On:
04 Apr 2014 10:50
Refereed?:
Yes
Published?:
Published
Last Modified:
22 Apr 2020 03:08